Navigation Links
Newest Adult Stem Therapy Treats Diabetes

Leaves Individuals With Juvenile Diabetes Insulin-Free

WASHINGTON, April 10, 2007 /PRNewswire-USNewswire/ -- In yet another advance in adult stem cell therapy, the Journal of the American Medical Association (JAMA) today released a study in which 14 of 15 Juvenile Diabetes patients demonstrated significant improvement as a result of an adult stem cell treatment. According to U.S. Rep. Dave Weldon, M.D. (R-FL), the study is significant in that it's the first attempt at using stem cells of any kind to reverse the effects of Type I diabetes in humans.

"This is a very promising study for those who are suffering from Juvenile Diabetes," said Weldon, a Florida physician, who noted that while only a preliminary study, the treatment appears to be quite promising since 14 of the patients remain insulin-free after the adult stem cell transplant using their own adult stem cells. One patient has now gone 34 months without insulin therapy.

"It's very important that the public be told what this is: an adult stem cell success, not the much touted embryo stem cell research. Also, one of the first things I noticed was that this research was done by Americans overseas. Why? Because much of the American biomedical research community has placed an irrational reliance on embryo stem cell research above all others. Adult stem cell science in America is being crowded out and in some cases ignored. This bias is now denying American patients access to therapies that are much more promising. We need to focus on human treatments for today, not those with false hope for tomorrow."

For years, Type I (Juvenile) diabetes has been known to be an autoimmune disorder where the body's own immune cells attack the insulin producing cell in the pancreas. These researchers used an adult stem cell transplant protocol that has previously been used with success in treating other autoimmune disorders such as lupus and MS (multiple s clerosis), crohns disease, scleroderma, and rheumatoid arthritis. The study was conducted in Brazil with the support of several U.S. clinical researchers.

"The beauty of the treatment protocol used here is that the patient's own bone marrow stem cells were used, guaranteeing a perfect match. There was no controversial destruction of human embryos. Embryo stem cells form tumors and have never been shown to be safe for use in humans.

"Should these patients remain insulin-free, the treatment is likely to be particularly useful for those suffering from Juvenile Diabetes who have difficultly in maintaining proper insulin levels, as well as for those who have difficulty accessing appropriate health care," Weldon concluded.

Dave Weldon

CONTACT: Kurt Heath of the Office of Representative Dave Weldon,+1-202-225-3671 or +1-202-210-3844

Web site: http://weldon.house.gov/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
3. Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia
4. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
5. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
6. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
7. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
8. Major Manufacturer of Unapproved and Adulterated Drugs
9. FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications
10. New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
11. Eighty-one Percent of U.S. Adults say that Birth Control Pills and Procedures Should Be Covered by Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Dutch surgeons have launched a ground-breaking medical app to help doctors ... a global scale. Medical professionals from Europe , ... the US have already signed up for the app, which combines ... environment. Education  "Imagine a doctor for Medicines ... at Harvard to treat a bomb victim via live streaming - ...
(Date:5/23/2016)... -- Global Paclitaxel Market 2016 Industry Research ... and the Paclitaxel analysis in this study is supported ... its players. This is the latest Paclitaxel ... current state of the industry while providing a basic ... industry chain structure. The Paclitaxel market analysis is provided ...
(Date:5/23/2016)... NEW YORK , May 23, 2016 /PRNewswire/ ... Mass Spectrometry Market Size, Share, Development, Growth and ... Platform (Hybrid, Single and Other), by Application (Drug ... Others), by End Users (Pharmaceuticals, Life Science and ... Published by P&S Market Research, the global ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... Today Omega Institute, a ... 11 innovative workshops and training opportunities in the growing field of ... of individuals who are dealing with specific health issues—including injuries, illnesses, and temporary or ...
(Date:5/25/2016)... ... 2016 , ... Cheryl Bowker of Bowker Insurance Group has been presented with ... Legacy Award. McKenna ran one of Allstate’s most successful agencies for 48 years, but ... knew him. The award named for him is not given every year, but only ...
(Date:5/25/2016)... FL (PRWEB) , ... May 25, 2016 , ... The ... dive into the unique integrative medical wellness offerings of Europe, a continent that pioneered ... Tyrol, Austria will hear from numerous pioneers in medical wellness, including Henri Chenot, Founder ...
(Date:5/25/2016)... FL (PRWEB) , ... May 25, 2016 , ... ... Cross Benefit Clearinghouse supporting the real time adjudication of medical service claims by ... providers using their current medical claims management software. The TransactRx Cross Benefit Clearinghouse ...
(Date:5/25/2016)... ... May 25, 2016 , ... Conrad Siegel Actuaries, delivering ... and Prescription Drug survey , an employee benefits survey measuring how ... in December 2015, indicates that employers are turning to consumer directed health care ...
Breaking Medicine News(10 mins):